G64E (p.Gly64Glu) variant of ATXN1 (Ataxin-1)

G64E (p.Gly64Glu) in ATXN1 (Ataxin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.

G64E (p.Gly64Glu) variant details